Vantage BioTrials Successfully Manages Real-World Effectiveness of Adalimumab in Patients with Moderate-to-Severe Hidradenitis Suppurativa: the 1-Year SOLACE Study

August 30, 2021, Montréal, Canada – Vantage BioTrials, a full service Contract Research Organization (CRO), is proud to have successfully managed, and completed approximately 12 months in advance, a Phase IV observational, multicentre, postmarketing study in adult patients with a clinical diagnosis of moderate-to-severe Hidradenitis suppurativa (HS).

NewsGuest UserSeptember 15, 2021vantage biotrials, CRO, phase IV

Are you Familiar with NMX Research and Solutions? BIOQuébec: More than 100 Organizations which Boost Quebec’s Economy!

The BIOQuébec network consists of more than 100 life sciences industry members.Discover more about NMX Research and Solutions in its profile!

NewsCatherine LamontagneJanuary 23, 2019BIOOQuébecnmx research, membership, BIOQuébec, CRO, Contract research

4th Edition of Pharmed CRO

BIOQuébec and Pharmed are hosting this forum on contract research organizations (CROs) in 2017. Benefit from a $100 discount off the regular price of $395!